{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:20:08Z","timestamp":1790720408438,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012000","name":"All Japan Coffee Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.neulet.2007.12.034","type":"journal-article","created":{"date-parts":[[2007,12,28]],"date-time":"2007-12-28T10:51:39Z","timestamp":1198839099000},"page":"146-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["Caffeine activates the PI3K\/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells"],"prefix":"10.1016","volume":"432","author":[{"given":"Kazuhiro","family":"Nakaso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2007.12.034_bib1","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/jnr.21427","article-title":"Neuroprotective effects of caffeine against complex-I inhibition-induced apoptosis are mediated by inhibition of the Atm\/p53\/E2F-1 path in cerebeller granule neurons","volume":"85","author":"Alvira","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2007.12.034_bib2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","article-title":"Caffeine, postmenopausal estrogen, and risk of Parkinson's disease","volume":"60","author":"Ascherio","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2007.12.034_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/aje\/kwh312","article-title":"Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen","volume":"160","author":"Ascherio","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neulet.2007.12.034_bib4","first-page":"147","article-title":"Nongenetic causes of Parkinson's disease","volume":"70","author":"Chade","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neulet.2007.12.034_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice","volume":"203","author":"Dall\u2019Igna","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2007.12.034_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp.2005.065417","article-title":"Relationship between impulsive sensation seeking trails, smoking, alcohol, and caffeine intake, and Parkinson's disease","volume":"77","author":"Evans","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2007.12.034_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-8993(96)00968-7","article-title":"Neuroprotective effects of dopamine D2\/D3 agonist pramipexole against postischemic or methamphetamine-induced nigrostriatal neurons","volume":"742","author":"Hall","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2007.12.034_bib8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archneur.64.4.576","article-title":"Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson's disease","volume":"64","author":"Hancock","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2007.12.034_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/01.wnl.0000204446.82823.28","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease","volume":"66","author":"Hernan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2007.12.034_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease","volume":"52","author":"Hernan","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2007.12.034_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2006.05.003","article-title":"Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal model s of Parkinson's disease","volume":"248","author":"Kalda","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2007.12.034_bib12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbrc.2005.11.095","article-title":"Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteins","volume":"339","author":"Nakaso","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2007.12.034_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.1997.tb48412.x","article-title":"Adenosine A2A receptors and neuroprotection","volume":"825","author":"Ongini","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neulet.2007.12.034_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000071193","article-title":"A case\u2013control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease","volume":"546","author":"Ragonese","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neulet.2007.12.034_bib15","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson's disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neulet.2007.12.034_bib16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.291.3.358","article-title":"Neuroprotection in Parkinson's disease: mysteries, myths and misconceptions","volume":"291","author":"Schapira","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neulet.2007.12.034_bib17","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1212\/01.WNL.0000095214.53646.72","article-title":"Neuroprotection by caffeine and more specific A2A receptor antagonists in animal model of Parkinson's disease","volume":"61","author":"Schwarzschild","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2007.12.034_bib18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1212\/WNL.46.5.1275","article-title":"Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case\u2013control study in Germany","volume":"46","author":"Seidler","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2007.12.034_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00415-004-1706-3","article-title":"Life style risk of Parkinson's disease: association between decreased water intake and constipation","volume":"251","author":"Ueki","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2007.12.034_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.20307","article-title":"Risk and protective factors for Parkinson's disease: a study in Swedish twins","volume":"57","author":"Wirdefeldt","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2007.12.034_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(02)00069-1","article-title":"Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice","volume":"322","author":"Xu","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2007.12.034_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1523\/JNEUROSCI.3008-05.2006","article-title":"Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model pf Parkinson's disease","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2007.12.034_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jnr.20350","article-title":"Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability translation","volume":"79","author":"Youdim","year":"2005","journal-title":"J. Neurosci. Res."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439400701275X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030439400701275X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:06:50Z","timestamp":1759608410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030439400701275X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S030439400701275X"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2007.12.034","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caffeine activates the PI3K\/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2007.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}